Results 1 to 10 of about 2,666 (168)

Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registry. [PDF]

Int J Cancer
What's New? Balancing efficacy and tolerability is challenging in oncology, as standard dosing often prioritizes maximum tolerated doses over other patient needs. Here, the authors developed a predictive index to identify patients with increased probability of dose reduction in metastatic breast cancer and compared the real‐world effectiveness of ...
Marschner P, Ringwald K, Thill M, Zahn MO, Welt A, Nusch A, Kaltenecker G, Rodemer Y, Hagen V, Schock C, Kruggel L, Kaiser-Osterhues A, Klein D, Haug N, Stickeler E, Harbeck N, Wöckel A, Marschner N, Decker T, OPAL Registry Group.   +19 more
europepmc   +2 more sources

Leukemia cutis als Primärmanifestation einer akuten myeloischen Leukämie [PDF]

J Dtsch Dermatol Ges
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 6, Page 793-798, June 2026.
Winkler F, Brand R, Mehic D, Tuchmann F, Valero T, Strobl J.   +5 more
europepmc   +2 more sources

[Time for change: what must the high-quality surgical training network of tomorrow offer? : Perspectives and demands of the Young Forums of the Surgical Societies in Germany]. [PDF]

Chirurgie (Heidelb)
Schlottmann F, Schaaf S, Rösch RM, Dey Hazra ME, Herbolzheimer M, Drossard S, Schuffert L, Braun BJ, Keller SL, Motekallemi A, Mulorz J, Menghesha H, Lawson McLean A, Huber T, Bouffleur F, Freund G.   +15 more
europepmc   +1 more source

[Residency training in clinical practice]. [PDF]

Radiologie (Heidelb)
Soltani M, Molwitz I, Notohamoprodjo M.
europepmc   +1 more source

Unmet need for patients with metastatic triple-negative breast cancer initiating first-line treatment: data from the prospective German tumor registry OPAL. [PDF]

ESMO Real World Data Digit Oncol
Stickeler E, Decker T, Zahn MO, Thill M, Zaiss M, Nusch A, Teutsch C, Wang M, Kuske A, Ringwald K, Kruggel L, Harbeck N, Wöckel A, Welt A, Gratzke K, OPAL registry group.   +15 more
europepmc   +1 more source

[Status quo and experience of primary care providers with regard to the counseling and management of obesity - Results of a quantitative-exploratory survey of general practitioners in Germany]. [PDF]

Dtsch Med Wochenschr
Wangler J, Jansky M.
europepmc   +1 more source

[Aftercare for bereaved parents in neonatology: closing a gap in professional support]. [PDF]

Z Geburtshilfe Neonatol
Schouten E, Stern I, Flemmer A, Starrach T.   +3 more
europepmc   +1 more source

ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancer. [PDF]

BMC Cancer
Sahm SW, Neumann UP, Zahn MO, Schwittay M, Maintz C, Goehler T, Rubanov O, Hering-Schubert C, Janssen J, Stenzel K, Reinke J, Overkamp F.   +11 more
europepmc   +1 more source

[Strategies for mitigating antibiotic resistance in human medicine from the perspective of the Ministry of Health]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Clarici A.
europepmc   +1 more source